Juiwanna Kushner

Inhibition of Bcl-2 Synergistically Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Preclinical Models of FLT3-Mutated Acute Myeloid Leukemia

Jun Ma, Xinan Qiao, Tristan Knight et al. · Clinical Cancer Research · 2019 · 172 citations · Full text

Design, Synthesis, and Biological Evaluation of Analogues of the Antitumor Agent, 2-{4-[(7-Chloro-2-quinoxalinyl)oxy]phenoxy}propionic Acid (XK469)

Stuart Hazeldine, Lisa Polin, Juiwanna Kushner et al. · Journal of Medicinal Chemistry · 2001 · 111 citations

Connector Linkage, Chemoprevention Strategy, Pharmaceutical Chemistry +16

II. Synthesis and Biological Evaluation of Some Bioisosteres and Congeners of the Antitumor Agent, 2-{4-[(7-Chloro-2-quinoxalinyl)oxy]phenoxy}propionic Acid (XK469)

Stuart Hazeldine, Lisa Polin, Juiwanna Kushner et al. · Journal of Medicinal Chemistry · 2002 · 74 citations

Chemical Biology, Pharmaceutical Chemistry, Molecular Pharmacology +17

Cryptophycins-309, 249 and other cryptophycin analogs: Preclinical efficacy studies with mouse and human tumors

Jian Liang, Richard E. Moore, Eric D. Moher et al. · Investigational New Drugs · 2005 · 74 citations

Human Tumors, Tumor Biology, Chemoprevention Strategy +9

Synthesis, Biological, and Antitumor Activity of a Highly Potent 6-Substituted Pyrrolo[2,3-<i>d</i>]pyrimidine Thienoyl Antifolate Inhibitor with Proton-Coupled Folate Transporter and Folate Receptor Selectivity over the Reduced Folate Carrier That Inhibits β-Glycinamide Ribonucleotide Formyltransferase

Lei Wang, Sita Kugel Desmoulin, Christina Cherian et al. · Journal of Medicinal Chemistry · 2011 · 68 citations · Full text

Pharmaceutical Science, Pharmacotherapy, Pharmaceutical Chemistry +17